BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12377186)

  • 1. HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia.
    Tolba KA; Bowers WJ; Eling DJ; Casey AE; Kipps TJ; Federoff HJ; Rosenblatt JD
    Mol Ther; 2002 Oct; 6(4):455-63. PubMed ID: 12377186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia.
    Tolba KA; Bowers WJ; Hilchey SP; Halterman MW; Howard DF; Giuliano RE; Federoff HJ; Rosenblatt JD
    Blood; 2001 Jul; 98(2):287-95. PubMed ID: 11435295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
    Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
    Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
    Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.
    Mayr C; Kofler DM; Büning H; Bund D; Hallek M; Wendtner CM
    Blood; 2005 Nov; 106(9):3223-6. PubMed ID: 16014560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 activation: potential for specific immunotherapy in B-CLL.
    von Bergwelt-Baildon M; Maecker B; Schultze J; Gribben JG
    Ann Oncol; 2004 Jun; 15(6):853-7. PubMed ID: 15151939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.
    Schattner EJ; Mascarenhas J; Reyfman I; Koshy M; Woo C; Friedman SM; Crow MK
    Blood; 1998 Apr; 91(8):2689-97. PubMed ID: 9531577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.
    Biagi E; Dotti G; Yvon E; Lee E; Pule M; Vigouroux S; Gottschalk S; Popat U; Rousseau R; Brenner M
    Blood; 2005 Mar; 105(6):2436-42. PubMed ID: 15536147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors.
    Wendtner CM; Kofler DM; Mayr C; Bund D; Hallek M
    Leuk Lymphoma; 2004 May; 45(5):897-904. PubMed ID: 15291346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
    Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
    Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells.
    Biagi E; Yvon E; Dotti G; Amrolia PJ; Takahashi S; Popat U; Marini F; Andreeff M; Brenner MK; Rousseau RF
    Hum Gene Ther; 2003 Apr; 14(6):545-59. PubMed ID: 12718765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.
    Litzinger MT; Foon KA; Tsang KY; Schlom J; Palena C
    Leuk Res; 2010 Oct; 34(10):1351-7. PubMed ID: 20122733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules.
    Van den Hove LE; Van Gool SW; Vandenberghe P; Bakkus M; Thielemans K; Boogaerts MA; Ceuppens JL
    Leukemia; 1997 Apr; 11(4):572-80. PubMed ID: 9096698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
    Ranheim EA; Cantwell MJ; Kipps TJ
    Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules.
    Palena C; Foon KA; Panicali D; Yafal AG; Chinsangaram J; Hodge JW; Schlom J; Tsang KY
    Blood; 2005 Nov; 106(10):3515-23. PubMed ID: 16081691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
    Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
    Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
    Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
    Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.